Contributors
Latest:
Alison Morris on the Future of Screening for DistressAlison Morris, Hematology/Oncology Nurse Practitioner, Stanford Health Care, discusses her hopes for the future of screening for emotional and physical distress.
Latest:
New T-Cell Therapy Shows Improved Response in Resistant Multiple MyelomaA new T-cell therapy showed benefits in patients with relapsed/refractory multiple myeloma.
Latest:
Taking My Cancer Experience at Face ValueAfter multiple cancer surgeries, I'm now more confident than I was when I was living on "easy street."
Latest:
Buying Hope: Life After a Fertility-Threatening DiagnosisIt's all about having a plan. Plans give hope. Plans inspire.
Latest:
Who are Cancer Clinical Trials For: Guinea Pigs, Test Pilots or Prize Poodles?Expert D. Ross Camidge, M.D., Ph.D., offers tips for dealing with the stress of navigating clinical trials for cancer treatment.
Latest:
More Than Friends Organization: Bringing Help and Hope to Cancer SurvivorsMore Than Friends chairperson Elise Bourne-Busby talked about her breast cancer journey and the inspiration for the Latino/Caribbean/American initiative that is dedicated to servicing cancer survivors.
Latest:
How to Determine if A Nutritional Supplement is a Detriment for a Patient With CancerVitamins, herbal medicines and other nutritional products may be more harmful than helpful to individuals with cancer. Check with an expert before taking them.
Latest:
How A Second Opinion Gave Us More Opportunities to Seek Additional Cancer CareA caregiver sheds light on the trials and tribulations of his wife's cancer journey and describes his awe in watching his wife's strength.
Latest:
Associating Genes With Melanoma RiskMaria T. Landi, M.D., Ph.D., principal investigator at the National Cancer Institute (NCI) and National Institutes of Health (NIH) discusses a recent study that identified genetic variations that may be linked with increased melanoma risk.
Latest:
Preserving Eyebrows During Chemotherapy TreatmentRenata Marie Vestevich, founder and developer of Essential Eyebrow Solution (EES), discusses how this topical solution may be able to help patients keep their eyebrow hair while undergoing chemotherapy.
Latest:
Blake A. Morrison Discusses the Excitement in Myeloma ResearchBlake A. Morrison discusses the recent excitement in myeloma research.
Latest:
An Inspired Healer, Leader and GuideAn Extraordinary Healer essay honoring SANDRA TERRAZZINO, APRN, M.S.N., FNP-BC, AOCNP [HEMATOLOGY ONCOLOGY CLINIC, BROOKE ARMY MEDICAL CENTER, FORT SAM HOUSTON, TEXAS]
Latest:
In Approach to Breast Cancer, Consider More Than Screening GuidelinesHouse Call with Len Lichtenfeld, the deputy chief medical officer of the American Cancer Society.
Latest:
Seven Thoughts on Accepting Change After CancerLike in life, the only constant in cancer is change. Fighting it just adds to the misery.
Latest:
Blood Cancers' Bottom Line: The High Cost of Cancer CareMedical care for blood cancer imposes high out-of-pocket costs for patients and families.
Latest:
On the Web: Shared Decision-MakingShared decision-making is a collaborative process for building relationships between patients and providers.
Latest:
Julie Fleshman on the Role of Nutrition in the Life of a Patient With Pancreatic CancerJulie Fleshman, JD, MBA, president, CEO, Pancreatic Cancer Action Network, discusses the role of nutrition in the life of a patient with pancreatic cancer.
Latest:
Prostate Cancer: Regaining Control of the Pelvic FloorMen undergoing prostate cancer treatment should give special attention to ensuring good pelvic floor strength in order to reduce side effects of treatment and maximize urinary and sexual function.
Latest:
Retired Tennis Star to Run NYC Marathon for Cancer ResearchI will be out on the street in New York City on November 1 to cheer on James Blake.
Latest:
Getting Booked - StatGaining access to that top-notch doctor or medical center can present a larger hurdle for someone with an uncommon malignancy, but it is possible with a few tips.
Latest:
200 Miles - One Patient's Journey for MMRFMultiple myeloma advocate Eric Gelber makes history. Watch him as he makes his 200-mile journey.
Latest:
Rudolph Navari on Preventing CINV With OlanzapineRudolph Navari, discusses a study of olanzapine for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy.
Latest:
Thank You, CancerScott Hersh is a colon cancer survivor. His journey started in August 2012 when he was initially diagnosed with stage 3 colon cancer at 48 years old. His journey continued with metastatic colon cancer (stage 4) in September 2013 and a recurrence again in January 2016. Each time, he endured six months of chemotherapy and had two major abdominal surgeries - one in September 2012 and one in June 2014. He is currently halfway through his third chemotherapy tour of duty. He receives his treatment at Johns Hopkins Hospital and shared that he is extremely grateful for his dedicated doctors, nurses and their staff.
